HealthcareServices

Global Expanded Carrier Screening Market 2026–2030: Forecast Insights for Business Planning

February 24, 2026February 24, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the expanded carrier screening market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Expanded Carrier Screening Market expected to reach by 2030?

The expanded carrier screening market size has experienced rapid growth in recent years. It is projected to expand from $2.46 billion in 2025 to $2.87 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.7%. The historical growth can be ascribed to factors such as increased awareness of inherited genetic disorders, the expansion of prenatal screening programs, advancements in genetic sequencing accuracy, a growing availability of diagnostic laboratories, and the rising adoption of carrier screening tools by clinicians.

The expanded carrier screening market is anticipated to experience significant expansion in the coming years. This market is forecast to reach a size of $5.28 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.4%. This projected growth during the forecast period is driven by several factors, including the surging demand for tailored reproductive health options, the increasing incorporation of AI-based variant analysis, the expansion of screening programs across populations, growing capital allocation towards genomic data platforms, and a heightened emphasis on proactive genetic healthcare. Key trends anticipated during this period involve the wider acceptance of pan-ethnic genetic screening panels, an escalating need for preconception carrier assessments, the expanding application of next-generation sequencing technologies, the proliferation of direct-to-provider genetic testing services, and a strengthened focus on integrating genetic counseling.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28215&type=smp

What Drivers Are Driving Adoption Within The Expanded Carrier Screening Market?

The increasing occurrence of genetic diseases is set to drive the expansion of the expanded carrier screening market in the future. These conditions are characterized by DNA abnormalities or mutations, which can be inherited or spontaneous. The rise in their prevalence is attributed to advancements in diagnostic tools like next-generation sequencing and other genomic technologies, which have significantly enhanced the detection and identification of many previously overlooked or misdiagnosed genetic disorders. Expanded carrier screening plays a crucial role by identifying carriers of these disorders prior to symptom onset, thus facilitating informed reproductive choices and lessening the risk of transmitting inherited conditions to subsequent generations. As an illustration, in October 2024, data from the Cystic Fibrosis Trust, a UK-based charity supporting cystic fibrosis patients, showed that registered patients for cystic fibrosis increased from 11,148 in 2022 to 11,318 in 2023, a 1.5% annual rise. Consequently, the growing prevalence of genetic diseases is fueling the growth of the carrier screening market.

How Is The Expanded Carrier Screening Market Organized Into Various Segments?

The expanded carrier screening market covered in this report is segmented –

1) By Type: Customized Panel Testing, Predesigned Panel Testing

2) By Technology: Deoxyribonucleic Acid Sequencing, Polymerase Chain Reaction, Microarrays, Other Technologies

3) By Application: Preconception, Prenatal, Other Applications

4) By End-User: Hospitals, Diagnostic Laboratories, Research Laboratories, Specialty Clinics, Other End-Users

Subsegments:

1) By Customized Panel Testing: Single Gene Testing, Multi-Gene Panel Testing, Ethnicity-Based Custom Panels, Condition-Specific Custom Panels, Family History-Based Custom Panels

2) By Predesigned Panel Testing: Pan-Ethnic Panels, Universal Carrier Panels, Population-Specific Panels, Disorder-Focused Panels, Expanded Predefined Panels

What Industry Trends Are Transforming The Expanded Carrier Screening Market?

Major companies operating in the expanded carrier screening market are prioritizing the creation of innovative solutions, such as comprehensive next-generation sequencing-based panels, aimed at identifying a diverse array of genetic conditions with enhanced precision and promptness. Comprehensive next-generation sequencing (NGS)-based panels represent sophisticated genetic tests that concurrently analyze numerous genes to pinpoint a broad spectrum of inherited disorders with remarkable accuracy and speed. For instance, in February 2023, the US-based genomic testing company Fulgent Genetics Inc. introduced the Beacon787 Expanded Carrier Screening Panel. This panel is designed to assess 787 genes associated with severe inherited conditions, offering extensive coverage of over 700 autosomal recessive and X-linked disorders, encompassing all Tier 3 genes. Utilizing advanced next-generation sequencing technology, it delivers high analytical accuracy, employs a pan-ethnic approach, and ensures a quick turnaround time of 2–3 weeks, thereby establishing itself as a leading comprehensive and precise reproductive carrier screening solution.

Who Are The Primary Competitors In The Global Expanded Carrier Screening Market?

Major companies operating in the expanded carrier screening market are Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific SE, Illumina Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., BGI Genomics Co. Ltd., Ambry Genetics Corporation, GeneDx Inc., BillionToOne Inc., MedGenome Labs Ltd., Centogene N.V., Baylor Miraca Genetics Laboratories LLC, Victorian Clinical Genetics Services, Pathkind Diagnostics Private Limited, Medicover Genetics GmbH, NxGen MDx LLC, GeneTech

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/expanded-carrier-screening-global-market-report

Which Regions Are Projected To Dominate The Expanded Carrier Screening Market In The Coming Years?

North America was the largest region in the expanded carrier screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the expanded carrier screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Expanded Carrier Screening Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28215&type=smp

Browse Through More Reports Similar to the Global Expanded Carrier Screening Market 2026, By The Business Research Company

Cellular Health Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/cellular-health-screening-global-market-report

Security Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/security-screening-global-market-report

Wireless Telecommunication Carrier Market Report 2026

https://www.thebusinessresearchcompany.com/report/wireless-telecommunication-carrier-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795